This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by JACOBSSON, B. Articles by COLLINS, V. P. Search for Related Content PubMed PubMed Citation Articles by JACOBSSON, B. Articles by COLLINS, V. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Pancreatic Cancer

Transthyretin Messenger Ribonucleic Acid Expression in the Pancreas and in Endocrine Tumors of the Pancreas and Gut^*

Departments of Pathology (B.J.) and Clinical Chemistry (A.C.), Danderyd Hospital Danderyd;
the Institute for Biochemistry, University of Stockholm (A.P.), and the Ludwig Institute for Cancer Research, Stockholm Branch (V.P.C.) Stockholm, Sweden

Address requests for reprints to: Dr. Björn Jacobsson, Department of Pathology, Danderyd Hospital, S-182 88 Danderyd, Sweden.

Transthyretin (TTR) cDNA probes were used to determine the presence of TTR mRNA in Northern blots from rat, porcine, and human organs as well as from human endocrine tumors. We also used in vitro translation in our study of the human tissues. In accordance with previous findings, TTR mRNA was found in the choroid plexus and, to a lesser extent, in the liver of all three species. In addition low levels of TTR mRNA were identified in the rat and human pancreas. All of the endocrine pancreatic tumors (two glucagonomas, two insulinomas, and one nonfunctional tumor) and the gut carcinoid also contained TTR mRNA, whereas other endocrine tumors (two pheochromocytomas and one paraganglioma) and one adenocarcinoma of the pancreas were TTR mRNA negative. The level of TTR mRNA expression in most of the endocrine pancreatic tumors exceeded that in the liver. The in vitro translations produced pre-TTR molecules of similar size for all TTR mRNA-positive human organs and tumors.

^* This work was supported by grants from the Swedish Medical Research Council (Project 03X-6231).

Received August 17, 1989.

This article has been cited by other articles:

				E. Refai, N. Dekki, S.-N. Yang, G. Imreh, O. Cabrera, L. Yu, G. Yang, S. Norgren, S. M. Rossner, L. Inverardi, et al. Transthyretin constitutes a functional component in pancreatic {beta}-cell stimulus-secretion coupling PNAS, November 22, 2005; 102(47): 17020 - 17025. [Abstract] [Full Text] [PDF]

				T. J. Giordano, L. J. Medeiros, V. Monterroso, W. M. Linehan, and M. J. Merino Transthyretin (Prealbumin) Immunoreactivity in Renal Cell Carcinoma and Other Neoplasms International Journal of Surgical Pathology, July 1, 1996; 4(1): 1 - 7. [Abstract] [PDF]